INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "ANTICANCER MACROCYCLIC QUINAZOLINE-BASED INHIBITORS OF THE INERACTION BETWEEN RAS AND SOS1"

GENEVA, Oct. 4 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/057645) for "ANTICANCER MACROCYCLIC QUINAZOLINE-BASED INHIBITORS OF THE INERACTION BETWEEN RAS AND SOS1" on Mar 20, 2025. With publication no. WO/2025/202022, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STELLFELD, Timo (c/o Nuvisan ICB GmbH,Mullerstrasse 17813353 Berlin), PAPE, Felix (c/o Nuvisan ICB GmbH,Mullerstrasse 17813353 Berlin), BUXTON, Craig Stephen (c/o Nuvisan ICB GmbH,Mullerstrasse 178...